Boston Scientific Corporation
BSX
#369
Rank
$69.809 B
Marketcap
United States
Country
$48.17
Share price
-5.90%
Change (1 day)
-55.30%
Change (1 year)
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use…
Key Metrics
Trailing P/E
17.45
Forward P/E
12.58
EPS (TTM)
$2.47
Forward EPS
$3.43
Price / Book
2.50
EV / EBITDA
13.3x
Beta
0.57
Dividend Yield
—
Return on Equity
15.34%
Return on Assets
6.19%
Debt / Equity
50.15
Current Ratio
1.24
Gross Margin
69.19%
Operating Margin
22.90%
Net Profit Margin
17.50%
Free Cash Flow
$2.451B
Charts
Price history and financial performance over time.
Price & Market Cap
Aug 18 – Sep 17
-14.61%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$20.074B
Latest Net Income$2.898B
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare Boston Scientific Corporation with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
BSX
No recent news available. Set FINNHUB_API_KEY to enable news.
